Whole Body Vibration in Chronic Obstructive Pulmonary Disease

Effects of Whole Body Vibration Training in Severe Chronic Obstructive Pulmonary Disease Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01850173

Enrollment

Registered

2013-05-09

Start date

2010-02-28

Completion date

2011-12-31

Last updated

2013-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

The investigators designed the current study with the main objective of determining whether Whole Body Vibration Training (WBVT) alone improves muscular force and/or modifies the functional capacity parameters in severe Chronic Obstructive Pulmonary Disease (COPD) patients referred to a rehabilitation programme.

Interventions

DEVICEA vertical vibration platform Fitybe

They performed 6 series, and each series consisted of four 30-second repetitions with a frequency of 35 Hz and 2 millimeters of amplitude, with 60 seconds of rest between each series.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Age

55 Years to 85 Years

Healthy volunteers

Yes

Inclusion criteria

* severe COPD defined as a post-bronchodilator forced expiratory volume at one second (FEV1)/ forced vital capacity (FVC) \< 0.7 and FEV1 \< 50% predicted, * stable disease defined as no exacerbation, * hospital admission or change in treatment in the previous 3 months.

Exclusion criteria

* other significant respiratory disease (bronchiectasis, * lung fibrosis, asthma, etc), * active smoking, * severe cardiovascular, * neurological, and/or metabolic pathology that could interfere with the results, * total hip, knee or ankle arthroplasty, * previous vitreous haemorrhage, * severe alcoholism (\> 80 g/day) and * severe malnutrition (BMI \< 19 Kg/m2) to reduce the risk of falling and dropouts.

Design outcomes

Primary

Measure	Time frame	Description
isokinetic knee flexor and extensor testing muscular force	basal, 3 months follow up	the change between basal - and 3 months follow up.
distance performed in the six minutes walking test (6MWT)	Basal, 3 months follow up	the change between basal - and 3 months follow up.

Secondary

Measure	Time frame	Description
respiratory muscular strength was assessed with maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)	Basal, 3 month follow up	the change between basal - and 3 months follow up.

Other

Measure	Time frame	Description
Complications	3 months follow up	cardiac events, increase in respiratory symptoms, knee pain during whole body vibration training.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026